BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lachant D, Bach C, Wilson B, Chengazi V, Goldman B, Lachant N, Pietropaoli A, Cameron S, James White R. Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus. Pulm Circ 2020;10:2045894020952019. [PMID: 33014336 DOI: 10.1177/2045894020952019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Lyhne MD, Witkin AS, Dasegowda G, Tanayan C, Kalra MK, Dudzinski DM. Evaluating cardiopulmonary function following acute pulmonary embolism. Expert Rev Cardiovasc Ther 2022. [PMID: 35920239 DOI: 10.1080/14779072.2022.2108789] [Reference Citation Analysis]
2 Newcomb G, Wilson BL, White RJ, Goldman B, Lachant NA, Lachant DJ. An Untapped Resource: Characteristics of Thrombus Recovered from Intermediate or High Risk Pulmonary Embolus Patients. Cardiovasc Pathol 2021;:107392. [PMID: 34718141 DOI: 10.1016/j.carpath.2021.107392] [Reference Citation Analysis]
3 Roto D, Lachant NA, James White R, Lachant DJ. Resting heart rate as a surrogate for improvement in intermediate risk pulmonary embolus patients? Respir Med 2021;187:106578. [PMID: 34416617 DOI: 10.1016/j.rmed.2021.106578] [Reference Citation Analysis]
4 Boon GJAM, Huisman MV, Klok FA. Determinants and Management of the Post-Pulmonary Embolism Syndrome. Semin Respir Crit Care Med 2021;42:299-307. [PMID: 33548930 DOI: 10.1055/s-0041-1722964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lachant DJ, Bach C, Fe A, White RJ, Lachant NA. Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli. ERJ Open Res 2021;7:00554-2020. [PMID: 33569503 DOI: 10.1183/23120541.00554-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]